146
Views
30
CrossRef citations to date
0
Altmetric
Original Research

Effect of particle size on oral absorption of carvedilol nanosuspensions: in vitro and in vivo evaluation

, , , , , & show all
Pages 6425-6434 | Published online: 13 Oct 2015

References

  • KawabataYWadaKNakataniMYamadaSOnoueSFormulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applicationsInt J Pharm2011420111021884771
  • ChenHKhemtongCYangXChangXGaoJNanonization strategies for poorly water-soluble drugsDrug Discov Today201116735436020206289
  • LipinskiCAPoor aqueous solubility-an industry wide problem in ADME screeningAm Pharm Rev200258285
  • LipinskiCALombardoFDominyBWFeeneyPJExperimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdv Drug Deliv Rev201264417
  • PaudelAWorkuZAMeeusJGunsSVan den MooterGManufacturing of solid dispersions of poorly water soluble drugs by spray drying: formulation and process considerationsInt J Pharm2013453125328422820134
  • YanY-DSungJHKimKKNovel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changesInt J Pharm2012422120221022085435
  • ShakeelFFaisalMSNanoemulsion: a promising tool for solubility and dissolution enhancement of celecoxibPharm Dev Technol2010151535619552546
  • TaoTZhaoYWuJZhouBPreparation and evaluation of itraconazole dihydrochloride for the solubility and dissolution rate enhancementInt J Pharm2009367110911418930795
  • BreitenbachJMelt extrusion: from process to drug delivery technologyEur J Pharm Biopharm200254210711712191680
  • LakshmanJPCaoYKowalskiJSerajuddinATApplication of melt extrusion in the development of a physically and chemically stable high-energy amorphous solid dispersion of a poorly water-soluble drugMol Pharm200856994100219434852
  • FenskeDBChonnACullisPRLiposomal nanomedicines: an emerging fieldToxicol Pathol2008361212918337218
  • MohammedAWestonNCoombesAFitzgeraldMPerrieYLiposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stabilityInt J Pharm20042851233415488676
  • ZhuangCYLiNWangMPreparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailabilityInt J Pharm20103941–217918520471464
  • LinCChenFYeTA novel oral delivery system consisting in “drug-in cyclodextrin-in nanostructured lipid carriers” for poorly water-soluble drug: vinpocetineInt J Pharm20144651–2909624530388
  • LukyanovANTorchilinVPMicelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugsAdv Drug Deliv Rev20045691273128915109769
  • LuYParkKPolymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugsInt J Pharm2013453119821422944304
  • PatravaleVBDateAAKulkarniRMNanosuspensions: a promising drug delivery strategyJ Pharm Pharmacol200456782784015233860
  • NoyesAAWhitneyWRThe rate of solution of solid substances in their own solutionsJ Am Chem Soc18971912930934
  • ScholzAAbrahamssonBDieboldSMInfluence of hydrodynamics and particle size on the absorption of felodipine in labradorsPharm Res2002191424611837699
  • HintzRJJohnsonKCThe effect of particle size distribution on dissolution rate and oral absorptionInt J Pharm1989511917
  • XiaDCuiFPiaoHEffect of crystal size on the in vitro dissolution and oral absorption of nitrendipine in ratsPharm Res20102791965197620585842
  • SunWMaoSShiYLiLCFangLNanonization of itraconazole by high pressure homogenization: Stabilizer optimization and effect of particle size on oral absorptionJ Pharm Sci201110083365337321520089
  • WenHJiangHLuZCarvedilol ameliorates sympathetic nerve sprouting and electrical remodeling after myocardial infarction in ratsBiomed Pharmacother201064744645020359859
  • MorganTClinical pharmacokinetics and pharmacodynamics of carvedilolClin Pharmacokinet19942653353467914479
  • HokamaNHobaraNKameyaHOhshiroSSakanashiMRapid and simple micro-determination of carvedilol in rat plasma by high-performance liquid chromatographyJ Chromatogr B Biomed Sci Appl1999732123323810517241
  • LiuDXuHTianBFabrication of carvedilol nanosuspensions through the anti-solvent precipitation-ultrasonication method for the improvement of dissolution rate and oral bioavailabilityAAPS Pharm Sci Tech2012131295304
  • MosharrafMNyströmCThe effect of particle size and shape on the surface specific dissolution rate of microsized practically insoluble drugsInt J Pharm199512213547
  • JunghannsJ-UAMüllerRHNanocrystal technology, drug delivery and clinical applicationsInt J Nanomed200833295
  • MüllerRJacobsCKayserONanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the futureAdv Drug Deliv Rev200147131911251242
  • PorterCJTrevaskisNLCharmanWNLipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugsNat Rev Drug Discov20076323124817330072
  • AnderbergEKArturssonPEpithelial transport of drugs in cell culture. VIII: effects of sodium dodecyl sulfate on cell membrane and tight junction permeability in human intestinal epithelial (Caco-2) cellsJ Pharm Sci19938243923988468683
  • LiuDYuSZhuZControlled delivery of carvedilol nanosuspension from osmotic pump capsule: in vitro and in vivo evaluationInt J Pharm20144751–249650325219321